News & AnalysisBiolinq attracts $100m Series BBiolinq Incorporated, a medical device company, has secured $100 million in Series B financing.ByIris Dorbian3 November 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs